Figure 2.
Objective responses in patients treated with CART-ddBCMA. Responses were assessed according to the IMWG consensus criteria. MRD status is also indicated along with extent of MRD, presented as the number of multiple myeloma cells detected in the bone marrow per 1 × 104, 1 × 105, or 1 × 106 total nucleated cells. An MRD of ≤1 × 10−4 is considered MRD-negative. (A) The best responses for each patient are shown, grouped by dose cohorts. (B) OR and sCR/CR rate over time.
